Aurobindo Pharma buyback details. Informing the Indian exchanges about the share buyback move, Aurobindo Pharma said, “In ...

Aurobindo Pharma will be carrying out the share buyback via the "tender offer" route, which means that all the potential ...

The buyback will be at a price of ₹1,475 per equity share payable in cash for an aggregate amount up to ₹800 crore.

The board has set April 17 as the record date for the purpose of determining the entitlement and the names of equity ...

Aurobindo Pharma plans to buy back up to 54,23,728 shares, which is about 0.93% of its total shares. It will buy these shares ...

The company has fixed April 17, 2026, as the record date to determine the eligibility of shareholders who can participate in ...

Company offers Rs 1,475 per share, about 10 per cent above market price; acceptance ratio and small size may limit gains.

The drug maker said its board has approved a share buyback of up to Rs 800 crore at a price of Rs 1,475 per equity share through the tender offer route.

Aurobindo Pharma transfers its domestic branded generic business to Auropharm for ₹143 crore to enhance growth and efficiency ...

Aurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 ...

After a rough regulatory start to the year, India’s Aurobindo Pharma is charting plans for growth. The Hyderabad-based generics juggernaut will plow 3 billion Indian rupees (about $37.7 million) into ...

https://www.thehindubusinessline.com/markets/watch-these-4-pharma-stocks-in-todays-trade-lupin-dr-reddys-aurobindo-biocon/article70397639.ece Copy Lupin Manufacturing ...